ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
GMO International Quality ETF

GMO International Quality ETF (QLTI)

22.7429
-0.0191
(-0.08%)
Closed 05 January 8:00AM
22.766
0.0231
(0.10%)
After Hours: 11:59AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
22.7429
Bid
-
Offer
-
Volume
3,304
22.69 Day's Range 22.98
22.49 52 Week Range 25.10
Previous Close
22.762
Open
22.98
Last Trade
100
@
22.7429
Last Trade Time
Average Volume (3m)
8,184
Financial Volume
US$ 75,197
VWAP
22.7593

QLTI Latest News

QLT Inc. establishes sales force in the United States

- QLT Ophthalmics, Inc. will market Visudyne(R) to retinal specialists across the U.S.- VANCOUVER, Dec. 22 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") is...

QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis

VANCOUVER, Dec. 15 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in...

6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy

VANCOUVER, Dec. 9 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") welcomed the 6-month results from the Novartis-sponsored EVEREST study which were presented...

QLT announces MGH litigation settlement

VANCOUVER, Nov. 25 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced the settlement of its litigation with the General Hospital Corporation...

QLT announces Toronto Stock Exchange approval of share repurchase program

VANCOUVER, Oct. 28 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT") announced that the Toronto Stock Exchange ("TSX") has accepted the notice of QLT's intention to make a...

QLT Announces Share Repurchase Program

VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that its board of directors has authorized the repurchase of up to 5% of...

QLT announces third quarter results for 2009

QLT SEPARATELY ANNOUNCES SHARE REPURCHASE PROGRAM VANCOUVER, Oct. 27 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today reported financial results for the...

QLT Gets Exclusive U.S. Rights To Visudyne

QLT Inc. (QLTI) will soon have exclusive U.S. sales and marketing rights to Visudyne after reaching a restructured agreement with Novartis Pharma AG (NVG), its marketing partner. Visudyne was the...

QLT restructures Visudyne(R) agreement

RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON SALES OUTSIDE THE U.S. VANCOUVER, Oct. 19 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today...

QLT announces sale of QLT USA, Inc. for up to US$230 million

VANCOUVER, Oct. 1 /PRNewswire-FirstCall/ -- QLT Inc. (NASDAQ: QLTI; TSX: QLT) ("QLT" or the "Company") today announced that it has completed the sale of all of the shares of its wholly-owned...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.4571-1.9702586206923.223.522.5442322.91885401SP
4-1.5571-6.4078189300424.324.3322.49419023.47072619SP
12-2.1071-8.4792756539224.8525.122.49818423.77691576SP
26-2.1071-8.4792756539224.8525.122.49818423.77691576SP
52-2.1071-8.4792756539224.8525.122.49818423.77691576SP
156-2.1071-8.4792756539224.8525.122.49818423.77691576SP
260-2.1071-8.4792756539224.8525.122.49818423.77691576SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IBGIronbark Zinc Limited
AUD 0.255
(8,400.00%)
113.37k
KATOKatana Capital
AUD 0.003
(200.00%)
77.1k
TTMOTitan Minerals Limited
AUD 0.03
(87.50%)
12.33k
EELENRG Elements Ltd
AUD 0.0015
(50.00%)
10M
CCOOAThe Calmer Co International Ltd
AUD 0.0015
(50.00%)
2.21M
NRZONeuRizer Ltd
AUD 0.001
(-50.00%)
1.01M
EATEntertainment Rewards Ltd
AUD 0.002
(-50.00%)
968.35k
NACONAOS Ex50 Opportunities Company Limited
AUD 0.002
(-33.33%)
13.37k
PNTOAPanther Metals Ltd
AUD 0.002
(-33.33%)
47k
KNBOKoonenberry gold Ltd
AUD 0.005
(-28.57%)
1.63M
GCMGreen Critical Minerals Ltd
AUD 0.019
(5.56%)
117.1M
ROGRed Sky Energy Limited
AUD 0.009
(-14.29%)
74.61M
IMUImugene Limited
AUD 0.039
(4.00%)
46.15M
BRNBrainchip Holdings Ltd
AUD 0.415
(-4.05%)
35.04M
TMGTrigg Minerals Ltd
AUD 0.045
(4.65%)
28.2M

Discussion

View Full Feed
devil dog 96 devil dog 96 5 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 5 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 9 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 9 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 29 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 32 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 33 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 33 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 34 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 35 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 36 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 37 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 38 minutes ago
Probably
AVXL
HokieHead HokieHead 40 minutes ago
Wrong..
TWOH
HokieHead HokieHead 41 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 42 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 44 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 44 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 45 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 45 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 46 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 47 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 49 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL

Your Recent History

Delayed Upgrade Clock